1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Synthesis Service Market Size Growth Rate by Type: 2017 VS 2022 VS 2030
1.2.2 mRNA Vaccine Synthesis
1.2.3 mRNA Drug Synthesis
1.3 Market by Application
1.3.1 Global mRNA Synthesis Service Market Share by Application: 2017 VS 2022 VS 2030
1.3.2 Clinical
1.3.3 Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global mRNA Synthesis Service Market Perspective (2017-2030)
2.2 mRNA Synthesis Service Growth Trends by Region
2.2.1 mRNA Synthesis Service Market Size by Region: 2017 VS 2022 VS 2030
2.2.2 mRNA Synthesis Service Historic Market Size by Region (2017-2023)
2.2.3 mRNA Synthesis Service Forecasted Market Size by Region (2023-2030)
2.3 mRNA Synthesis Service Market Dynamics
2.3.1 mRNA Synthesis Service Industry Trends
2.3.2 mRNA Synthesis Service Market Drivers
2.3.3 mRNA Synthesis Service Market Challenges
2.3.4 mRNA Synthesis Service Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top mRNA Synthesis Service Players by Revenue
3.1.1 Global Top mRNA Synthesis Service Players by Revenue (2017-2023)
3.1.2 Global mRNA Synthesis Service Revenue Market Share by Players (2017-2023)
3.2 Global mRNA Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Synthesis Service Revenue
3.4 Global mRNA Synthesis Service Market Concentration Ratio
3.4.1 Global mRNA Synthesis Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Synthesis Service Revenue in 2022
3.5 mRNA Synthesis Service Key Players Head office and Area Served
3.6 Key Players mRNA Synthesis Service Product Solution and Service
3.7 Date of Enter into mRNA Synthesis Service Market
3.8 Mergers & Acquisitions, Expansion Plans 4 mRNA Synthesis Service Breakdown Data by Type
4.1 Global mRNA Synthesis Service Historic Market Size by Type (2017-2023)
4.2 Global mRNA Synthesis Service Forecasted Market Size by Type (2023-2030) 5 mRNA Synthesis Service Breakdown Data by Application
5.1 Global mRNA Synthesis Service Historic Market Size by Application (2017-2023)
5.2 Global mRNA Synthesis Service Forecasted Market Size by Application (2023-2030) 6 North America
6.1 North America mRNA Synthesis Service Market Size (2017-2030)
6.2 North America mRNA Synthesis Service Market Size by Country (2017-2023)
6.3 North America mRNA Synthesis Service Market Size by Country (2023-2030)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe mRNA Synthesis Service Market Size (2017-2030)
7.2 Europe mRNA Synthesis Service Market Size by Country (2017-2023)
7.3 Europe mRNA Synthesis Service Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific mRNA Synthesis Service Market Size (2017-2030)
8.2 Asia-Pacific mRNA Synthesis Service Market Size by Country (2017-2023)
8.3 Asia-Pacific mRNA Synthesis Service Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America mRNA Synthesis Service Market Size (2017-2030)
9.2 Latin America mRNA Synthesis Service Market Size by Country (2017-2023)
9.3 Latin America mRNA Synthesis Service Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa mRNA Synthesis Service Market Size (2017-2030)
10.2 Middle East & Africa mRNA Synthesis Service Market Size by Country (2017-2023)
10.3 Middle East & Africa mRNA Synthesis Service Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 APExBIO
11.1.1 APExBIO Company Detail
11.1.2 APExBIO Business Overview
11.1.3 APExBIO mRNA Synthesis Service Introduction
11.1.4 APExBIO Revenue in mRNA Synthesis Service Business (2017-2023)
11.1.5 APExBIO Recent Development
11.2 Takeda Pharmaceuticals
11.2.1 Takeda Pharmaceuticals Company Detail
11.2.2 Takeda Pharmaceuticals Business Overview
11.2.3 Takeda Pharmaceuticals mRNA Synthesis Service Introduction
11.2.4 Takeda Pharmaceuticals Revenue in mRNA Synthesis Service Business (2017-2023)
11.2.5 Takeda Pharmaceuticals Recent Development
11.3 Tesla
11.3.1 Tesla Company Detail
11.3.2 Tesla Business Overview
11.3.3 Tesla mRNA Synthesis Service Introduction
11.3.4 Tesla Revenue in mRNA Synthesis Service Business (2017-2023)
11.3.5 Tesla Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific mRNA Synthesis Service Introduction
11.4.4 Thermo Fisher Scientific Revenue in mRNA Synthesis Service Business (2017-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 VGXI
11.5.1 VGXI Company Detail
11.5.2 VGXI Business Overview
11.5.3 VGXI mRNA Synthesis Service Introduction
11.5.4 VGXI Revenue in mRNA Synthesis Service Business (2017-2023)
11.5.5 VGXI Recent Development
11.6 WACKER Chemie
11.6.1 WACKER Chemie Company Detail
11.6.2 WACKER Chemie Business Overview
11.6.3 WACKER Chemie mRNA Synthesis Service Introduction
11.6.4 WACKER Chemie Revenue in mRNA Synthesis Service Business (2017-2023)
11.6.5 WACKER Chemie Recent Development
11.7 Siegfried
11.7.1 Siegfried Company Detail
11.7.2 Siegfried Business Overview
11.7.3 Siegfried mRNA Synthesis Service Introduction
11.7.4 Siegfried Revenue in mRNA Synthesis Service Business (2017-2023)
11.7.5 Siegfried Recent Development
11.8 ST Pharm
11.8.1 ST Pharm Company Detail
11.8.2 ST Pharm Business Overview
11.8.3 ST Pharm mRNA Synthesis Service Introduction
11.8.4 ST Pharm Revenue in mRNA Synthesis Service Business (2017-2023)
11.8.5 ST Pharm Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis mRNA Synthesis Service Introduction
11.9.4 Novartis Revenue in mRNA Synthesis Service Business (2017-2023)
11.9.5 Novartis Recent Development
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Detail
11.10.2 Novo Nordisk Business Overview
11.10.3 Novo Nordisk mRNA Synthesis Service Introduction
11.10.4 Novo Nordisk Revenue in mRNA Synthesis Service Business (2017-2023)
11.10.5 Novo Nordisk Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer mRNA Synthesis Service Introduction
11.11.4 Pfizer Revenue in mRNA Synthesis Service Business (2017-2023)
11.11.5 Pfizer Recent Development
11.12 LakePharma
11.12.1 LakePharma Company Detail
11.12.2 LakePharma Business Overview
11.12.3 LakePharma mRNA Synthesis Service Introduction
11.12.4 LakePharma Revenue in mRNA Synthesis Service Business (2017-2023)
11.12.5 LakePharma Recent Development
11.13 Lion TCR
11.13.1 Lion TCR Company Detail
11.13.2 Lion TCR Business Overview
11.13.3 Lion TCR mRNA Synthesis Service Introduction
11.13.4 Lion TCR Revenue in mRNA Synthesis Service Business (2017-2023)
11.13.5 Lion TCR Recent Development
11.14 Lonza
11.14.1 Lonza Company Detail
11.14.2 Lonza Business Overview
11.14.3 Lonza mRNA Synthesis Service Introduction
11.14.4 Lonza Revenue in mRNA Synthesis Service Business (2017-2023)
11.14.5 Lonza Recent Development
11.15 Merck
11.15.1 Merck Company Detail
11.15.2 Merck Business Overview
11.15.3 Merck mRNA Synthesis Service Introduction
11.15.4 Merck Revenue in mRNA Synthesis Service Business (2017-2023)
11.15.5 Merck Recent Development
11.16 GlaxoSmithKline
11.16.1 GlaxoSmithKline Company Detail
11.16.2 GlaxoSmithKline Business Overview
11.16.3 GlaxoSmithKline mRNA Synthesis Service Introduction
11.16.4 GlaxoSmithKline Revenue in mRNA Synthesis Service Business (2017-2023)
11.16.5 GlaxoSmithKline Recent Development
11.17 GenePharma
11.17.1 GenePharma Company Detail
11.17.2 GenePharma Business Overview
11.17.3 GenePharma mRNA Synthesis Service Introduction
11.17.4 GenePharma Revenue in mRNA Synthesis Service Business (2017-2023)
11.17.5 GenePharma Recent Development
11.18 Fareva
11.18.1 Fareva Company Detail
11.18.2 Fareva Business Overview
11.18.3 Fareva mRNA Synthesis Service Introduction
11.18.4 Fareva Revenue in mRNA Synthesis Service Business (2017-2023)
11.18.5 Fareva Recent Development
11.19 Fosun Pharma
11.19.1 Fosun Pharma Company Detail
11.19.2 Fosun Pharma Business Overview
11.19.3 Fosun Pharma mRNA Synthesis Service Introduction
11.19.4 Fosun Pharma Revenue in mRNA Synthesis Service Business (2017-2023)
11.19.5 Fosun Pharma Recent Development
11.20 GC Pharma
11.20.1 GC Pharma Company Detail
11.20.2 GC Pharma Business Overview
11.20.3 GC Pharma mRNA Synthesis Service Introduction
11.20.4 GC Pharma Revenue in mRNA Synthesis Service Business (2017-2023)
11.20.5 GC Pharma Recent Development
11.21 Syneos Health
11.21.1 Syneos Health Company Detail
11.21.2 Syneos Health Business Overview
11.21.3 Syneos Health mRNA Synthesis Service Introduction
11.21.4 Syneos Health Revenue in mRNA Synthesis Service Business (2017-2023)
11.21.5 Syneos Health Recent Development
11.22 Bayer
11.22.1 Bayer Company Detail
11.22.2 Bayer Business Overview
11.22.3 Bayer mRNA Synthesis Service Introduction
11.22.4 Bayer Revenue in mRNA Synthesis Service Business (2017-2023)
11.22.5 Bayer Recent Development
11.23 Beijing Tricision Biotherapeutics
11.23.1 Beijing Tricision Biotherapeutics Company Detail
11.23.2 Beijing Tricision Biotherapeutics Business Overview
11.23.3 Beijing Tricision Biotherapeutics mRNA Synthesis Service Introduction
11.23.4 Beijing Tricision Biotherapeutics Revenue in mRNA Synthesis Service Business (2017-2023)
11.23.5 Beijing Tricision Biotherapeutics Recent Development
11.24 Cellerna
11.24.1 Cellerna Company Detail
11.24.2 Cellerna Business Overview
11.24.3 Cellerna mRNA Synthesis Service Introduction
11.24.4 Cellerna Revenue in mRNA Synthesis Service Business (2017-2023)
11.24.5 Cellerna Recent Development
11.25 Eli Lilly
11.25.1 Eli Lilly Company Detail
11.25.2 Eli Lilly Business Overview
11.25.3 Eli Lilly mRNA Synthesis Service Introduction
11.25.4 Eli Lilly Revenue in mRNA Synthesis Service Business (2017-2023)
11.25.5 Eli Lilly Recent Development
11.26 CMC Pharmaceuticals
11.26.1 CMC Pharmaceuticals Company Detail
11.26.2 CMC Pharmaceuticals Business Overview
11.26.3 CMC Pharmaceuticals mRNA Synthesis Service Introduction
11.26.4 CMC Pharmaceuticals Revenue in mRNA Synthesis Service Business (2017-2023)
11.26.5 CMC Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
